AUP Insider Trading (Aurinia Pharmaceuticals)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$2,227,165.60
Insider Selling (Last 12 Months): C$3,919,165.00
Aurinia Pharmaceuticals Share Price & Price History
Current Price: C$16.76
Price Change: ▼ Price Decrease of -0.61 (-3.51%)
As of 07/30/2021 01:00 AM ET
The Safest Way To Start Trading Is Here!
From Tradewins | Ad
One look at Wall Street right now and anyone can tell: it’s a mess! But new trades can get an edge with “Options Trading Made Easy” by trading champion Chuck Hughes, the best guide to options trading in the modern market.
Start with a small investment today and see where you can go!
Get your copy now!
>>>
Aurinia Pharmaceuticals Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/11/2021 | Michael Robert Martin | Director | Buy | 29,000 | C$28.82 | C$835,780.00 | 61,824 | |
| 11/10/2021 | Neil Solomons | Senior Officer | Buy | 70,000 | C$8.00 | C$559,944.00 | 157,299 | |
| 11/9/2021 | Michael Robert Martin | Director | Sell | 50,000 | C$39.82 | C$1,991,220.00 | 92,824 | |
| 10/25/2021 | Robert Huizinga | Senior Officer | Buy | 95,000 | C$4.22 | C$401,280.00 | 195,728 | |
| 9/21/2021 | Robert Huizinga | Senior Officer | Buy | 16,000 | C$3.47 | C$55,545.60 | 122,092 | |
| 9/20/2021 | Michael Robert Martin | Director | Buy | 28,500 | C$7.00 | C$199,386.00 | 171,324 | |
| 9/13/2021 | Michael Robert Martin | Director | Buy | 25,000 | C$7.01 | C$175,230.00 | 167,824 | |
| 9/10/2021 | Robert Huizinga | Senior Officer | Sell | 32,500 | C$27.92 | C$907,335.00 | 106,092 | |
| 9/7/2021 | Michael Robert Martin | Director | Sell | 7,500 | C$23.89 | C$179,190.00 | 142,824 | |
| 9/7/2021 | Robert Huizinga | Senior Officer | Sell | 5,000 | C$24.16 | C$120,780.00 | 138,592 | |
| 8/26/2021 | Michael Robert Martin | Director | Sell | 22,500 | C$23.51 | C$528,957.00 | 150,324 | |
| 8/25/2021 | Neil Solomons | Senior Officer | Sell | 5,000 | C$20.92 | C$104,610.00 | 137,299 | |
| 7/28/2021 | Michael Robert Martin | Director | Sell | 5,000 | C$17.41 | C$87,073.00 | 177,824 | |
| 6/22/2021 | Michael Robert Martin | Director | Sell | 5,000 | C$17.01 | C$85,050.00 | 182,824 | |
| 1/28/2021 | Stephen P. Robertson | Senior Officer | Buy | 900 | C$21.30 | C$19,174.32 | 2,720 | |
| 9/21/2020 | Chin Kyu Huh | Insider | Sell | 48,458 | C$19.91 | C$964,988.54 | 6,499,881 | |
| 8/18/2020 | Robert Huizinga | Senior Officer | Sell | 14,000 | C$19.01 | C$266,176.40 | 103,592 | |
| 7/8/2020 | Neil Solomons | Senior Officer | Sell | 10,000 | C$21.15 | C$211,500.00 | 187,299 | |
| 4/9/2020 | Neil Solomons | Senior Officer | Sell | 4,100 | C$21.04 | C$86,279.17 | 197,299 | |
| 4/6/2020 | Neil Solomons | Senior Officer | Sell | 15,000 | C$21.11 | C$316,617.00 | 202,299 | |
| 1/2/2020 | Dennis Bourgeault | Senior Officer | Sell | 3,000 | C$27.62 | C$82,860.00 | 70,891 | |
| 12/16/2019 | Dennis Bourgeault | Senior Officer | Sell | 5,000 | C$24.08 | C$120,400.00 | 73,891 | |
| 12/12/2019 | Dennis Bourgeault | Senior Officer | Sell | 5,000 | C$24.55 | C$122,750.00 | 16,452 | |
| 10/15/2019 | Joseph Patrick Hagan | Director | Buy | 2,000 | C$6.28 | C$12,553.20 | 3,500 | |
| 10/14/2019 | Bradley Dickerson | Senior Officer | Buy | 5,000 | C$5.11 | C$25,542.00 | 15,000 | |
| 10/11/2019 | Joseph Patrick Hagan | Director | Buy | 1,500 | C$5.11 | C$7,660.03 | 1,500 | |
| 9/26/2019 | Stephen P. Robertson | Senior Officer | Buy | 1,050 | C$7.44 | C$7,812.00 | 1,820 | |
Make Sure Your Alarm Is Set…
From Base Camp Trading | Ad
This early morning trade is constantly overlooked, but those who use it are retiring early!
Hi, I’m trading expert Dave Aquino and with my new guide, “How To Master The Retirement Trade”, you could be taking advantage of it as well!
The trade starts at 9:30EST…don’t be late!
Get a copy here!
>>>
SEC Filings (Institutional Ownership Changes) for Aurinia Pharmaceuticals (TSE:AUP)
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Read More on Aurinia Pharmaceuticals
Today's Range
Now: C$16.76
Low: C$16.41
High: C$17.46
50 Day Range
MA: N/A
52 Week Range
Now: C$16.76
Low: C$11.77
High: C$26.00
Volume
4,611,683 shs
Average Volume
229,895 shs
Market Capitalization
C$2.15 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Aurinia Pharmaceuticals?
